NASDAQ:SRTS Sensus Healthcare (SRTS) Stock Price, News & Analysis $3.03 -0.07 (-2.26%) Closing price 09/23/2026 04:00 PM EasternExtended Trading$3.03 0.00 (0.00%) As of 09/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Sensus Healthcare Stock (NASDAQ:SRTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sensus Healthcare alerts:Sign Up Key Stats Today's Range$3.02▼$3.1350-Day Range$2.85▼$3.5452-Week Range$2.66▼$5.49Volume45,378 shsAverage Volume32,941 shsMarket Capitalization$49.88 millionP/E RatioN/ADividend YieldN/APrice Target$5.83Consensus RatingModerate Buy Company Overview Sensus Healthcare, Inc. is a medical device company focused on noninvasive treatments for dermatologic and oncologic conditions. The company develops and commercializes superficial radiation therapy systems designed to deliver low-energy X-rays to targeted areas of the skin while limiting exposure to surrounding tissue. Its principal products include the SRT-100 and SRT-100 Vision systems, which are used primarily to treat non-melanoma skin cancers such as basal cell and squamous cell carcinomas, as well as certain keloid scars. The SRT-100 Vision incorporates image-guidance capabilities intended to support treatment planning and delivery. Sensus has also developed dermatology and aesthetic treatment technologies, including systems designed for transdermal drug delivery. Founded in 2010, Sensus Healthcare is headquartered in Boca Raton, Florida. The company markets its products to dermatology practices, hospitals, cancer treatment centers and other healthcare providers in the United States and selected international markets through a combination of direct sales and distribution relationships.AI Generated. May Contain Errors. Read More Sensus Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreSRTS MarketRank™: Sensus Healthcare scored higher than 62% of companies evaluated by MarketBeat, and ranked 306th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingSensus Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialSensus Healthcare has a consensus price target of $5.83, representing about 92.5% upside from its current price of $3.03.Amount of Analyst CoverageSensus Healthcare has only been the subject of 3 research reports in the past 90 days.Read more about Sensus Healthcare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Sensus Healthcare's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.46% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 3.77, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sensus Healthcare has recently increased by 3.34%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment0.51 News SentimentSensus Healthcare has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Sensus Healthcare this week, compared to 2 articles on an average week. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $405,230.00 in company stock, which represents 0.8124% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $405,230.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions25.30% of the stock of Sensus Healthcare is held by institutions.Read more about Sensus Healthcare's insider trading history. Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTS Stock News HeadlinesSensus Healthcare, Inc. (NASDAQ:SRTS) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 23 at 4:45 AM | americanbankingnews.comSensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Purchases 27,304 Shares of StockSeptember 1, 2026 | insidertrades.comWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.September 24 at 1:00 AM | Stansberry Research (Ad)Sensus Healthcare IncAugust 31, 2026 | money.usnews.comInsider Buying: Sensus Healthcare (NASDAQ:SRTS) Director Buys $31,939.32 in StockAugust 29, 2026 | insidertrades.comSensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Acquires 34,697 SharesAugust 26, 2026 | insidertrades.comSensus (SRTS) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | finance.yahoo.comSensus outlines shift to $250,000 average selling price as it targets a stronger second halfAugust 14, 2026 | seekingalpha.comSee More Headlines SRTS Stock Analysis - Frequently Asked Questions How have SRTS shares performed this year? Sensus Healthcare's stock was trading at $3.98 at the beginning of 2026. Since then, SRTS stock has decreased by 23.9% and is now trading at $3.03. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) issued its earnings results on Thursday, August, 13th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.41. The business had revenue of $2.29 million for the quarter, compared to analysts' expectations of $4.60 million. Sensus Healthcare had a negative net margin of 88.45% and a negative trailing twelve-month return on equity of 21.57%. Read the conference call transcript. When did Sensus Healthcare IPO? Sensus Healthcare (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. Who are Sensus Healthcare's major shareholders? Sensus Healthcare's top institutional investors include Bank of New York Mellon Corp (0.61%), BlackRock Inc. (0.51%) and EP Wealth Advisors LLC (0.10%). Insiders that own company stock include Joseph C Sardano, Eric Sachetta, Michael Sardano and John Heinrich. View institutional ownership trends. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET). Company Calendar Last Earnings8/13/2026Today9/23/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 SRTS's financial health is in the Yellow zone, according to TradeSmith. SRTS has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SRTS CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees60Year Founded2010Price Target and Rating Average Price Target for Sensus Healthcare$5.83 High Price Target$7.50 Low Price Target$4.00 Potential Upside/Downside+92.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.72 million Net Margins-88.45% Pretax Margin-72.53% Return on Equity-21.57% Return on Assets-19.20% Debt Debt-to-Equity RatioN/A Current Ratio8.71 Quick Ratio4.30 Sales & Book Value Annual Sales$17.51 million Price / Sales2.85 Cash FlowN/A Price / Cash FlowN/A Book Value$2.93 per share Price / Book1.03Miscellaneous Outstanding Shares16,462,000Free Float14,783,000Market Cap$49.88 million OptionableOptionable Beta1.13 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SRTS) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRTS Stock Alerts